Prestige Brand Holdings Inc (PBH)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE
Market Cap: $2.19B
Last updated: Nov 17, 2026 at 11:06 AM ET
Prestige Brand Holdings Inc (PBH) Earnings: Report Dates and Results
Prestige Brand Holdings (PBH) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Prestige Brand Holdings reported EPS of $1.13, above the $1.06 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PBH has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 7.9% below the $1.14 reported for the quarter ended Dec 31, 2025.
PBH Earnings Call
The latest PBH earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, PBH beat 31, missed 7 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $336.31M, up 22.7% from $274.11M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $1.13 | $1.06 | $1.06 - $1.08 | +6.60% | Beat | +31.4% | 7 | 0 up, 1 down | Nov 5, 2026 | $336.31M |
| Jun 30, 2026 | $0.98 | $0.89 | $0.87 - $0.89 | +10.11% | Beat | +3.2% | 6 | 0 up, 3 down | Aug 6, 2026 | $265.71M |
| Mar 31, 2026 | $1.23 | $1.39 | $1.38 - $1.40 | -11.51% | Miss | -6.8% | 6 | 0 up, 1 down | May 13, 2026 | $281.62M |
| Dec 31, 2025 | $1.14 | $1.16 | $1.14 - $1.22 | -1.72% | Miss | -6.6% | 7 | 1 up, 1 down | Feb 5, 2026 | $283.44M |
| Sep 30, 2025 | $0.86 | $0.97 | $0.97 - $0.97 | -11.34% | Miss | -21.1% | 7 | 0 up, 1 down | Nov 6, 2025 | $274.11M |
| Jun 30, 2025 | $0.95 | $1.01 | N/A | -5.94% | Miss | +5.6% | 5 | 0 up, 2 down | Aug 7, 2025 | $249.53M |
| Mar 31, 2025 | $1.32 | $1.29 | $1.24 - $1.30 | +2.33% | Beat | +29.4% | 8 | 4 up, 2 down | May 8, 2025 | $296.52M |
| Dec 31, 2024 | $1.22 | $1.16 | $1.14 - $1.16 | +5.17% | Beat | +15.1% | 7 | 0 up, 5 down | Feb 6, 2025 | $290.32M |
| Sep 30, 2024 | $1.09 | $1.08 | $1.08 - $1.10 | +0.93% | Beat | +1.9% | 7 | 0 up, 0 down | Nov 7, 2024 | $283.79M |
| Jun 30, 2024 | $0.90 | $0.86 | $0.86 - $0.86 | +4.65% | Beat | -15.1% | 6 | 0 up, 0 down | Aug 8, 2024 | $267.14M |
| Mar 31, 2024 | $1.02 | $1.14 | $1.14 - $1.14 | -10.53% | Miss | -4.7% | 6 | 0 up, 0 down | May 14, 2024 | $276.99M |
| Dec 31, 2023 | $1.06 | $1.04 | $1.04 - $1.05 | +1.92% | Beat | +1.9% | 6 | 0 up, 0 down | Feb 8, 2024 | $282.74M |
| Sep 30, 2023 | $1.07 | $1.07 | $1.05 - $1.07 | 0.00% | In line | +4.9% | 6 | 0 up, 0 down | Nov 2, 2023 | $286.32M |
| Jun 30, 2023 | $1.06 | $1.01 | $1.00 - $1.02 | +4.95% | Beat | -2.8% | 5 | 1 up, 0 down | Aug 3, 2023 | $279.31M |
| Mar 31, 2023 | $1.07 | $1.04 | $1.04 - $1.04 | +2.88% | Beat | +17.6% | 6 | 0 up, 0 down | May 4, 2023 | $285.87M |
| Dec 31, 2022 | $1.04 | $1.01 | $1.01 - $1.02 | +2.97% | Beat | +5.1% | 6 | 0 up, 0 down | Feb 2, 2023 | $275.52M |
| Sep 30, 2022 | $1.02 | $1.00 | $0.99 - $1.02 | +2.00% | Beat | 0.0% | 6 | 0 up, 1 down | Nov 3, 2022 | $289.27M |
| Jun 30, 2022 | $1.09 | $1.04 | N/A | +4.81% | Beat | -4.4% | N/A | 0 up, 0 down | Aug 4, 2022 | $277.06M |
| Mar 31, 2022 | $0.91 | $0.89 | $0.86 - $0.92 | +2.25% | Beat | +15.2% | 6 | 0 up, 0 down | May 5, 2022 | $266.94M |
| Dec 31, 2021 | $0.99 | $0.88 | $0.88 - $0.89 | +12.50% | Beat | +22.2% | 6 | N/A | Feb 3, 2022 | $274.47M |
| Sep 30, 2021 | $1.02 | $0.99 | $0.97 - $1.00 | +3.03% | Beat | +30.8% | 6 | 4 up, 0 down | Nov 4, 2021 | $276.23M |
| Jun 30, 2021 | $1.14 | $0.87 | $0.86 - $1.14 | +31.03% | Beat | +32.6% | 6 | N/A | Aug 5, 2021 | $269.18M |
| Mar 31, 2021 | $0.79 | $0.78 | $0.77 - $0.80 | +1.28% | Beat | -3.7% | 7 | N/A | May 6, 2021 | $237.76M |
| Dec 31, 2020 | $0.81 | $0.77 | $0.73 - $0.79 | +5.19% | Beat | 0.0% | 7 | N/A | Feb 4, 2021 | $238.79M |
| Sep 30, 2020 | $0.78 | $0.72 | $0.70 - $0.74 | +8.33% | Beat | +14.7% | 7 | N/A | Nov 5, 2020 | $237.42M |
| Jun 30, 2020 | $0.86 | $0.70 | $0.70 - $0.70 | +22.86% | Beat | +32.3% | 6 | N/A | Aug 6, 2020 | $229.39M |
| Mar 31, 2020 | $0.82 | $0.74 | $0.71 - $0.81 | +10.81% | Beat | +13.9% | 6 | N/A | May 7, 2020 | $254.00M |
| Dec 31, 2019 | $0.81 | $0.75 | $0.73 - $0.78 | +8.00% | Beat | +11.0% | 4 | N/A | Feb 6, 2020 | $241.55M |
| Sep 30, 2019 | $0.68 | $0.66 | $0.64 - $0.67 | +3.03% | Beat | +4.6% | 5 | N/A | Oct 31, 2019 | $238.07M |
| Jun 30, 2019 | $0.65 | $0.64 | $0.62 - $0.65 | +1.56% | Beat | -4.4% | 5 | N/A | Aug 1, 2019 | $232.15M |
| Mar 31, 2019 | $0.72 | $0.70 | $0.69 - $0.74 | +2.86% | Beat | +16.1% | 5 | N/A | May 9, 2019 | N/A |
| Dec 31, 2018 | $0.73 | $0.72 | $0.70 - $0.76 | +1.39% | Beat | +4.3% | 5 | N/A | Feb 7, 2019 | $724.24M |
| Sep 30, 2018 | $0.65 | $0.63 | $0.62 - $0.64 | +3.17% | Beat | +6.6% | 5 | N/A | Nov 1, 2018 | $239.36M |
| Jun 30, 2018 | $0.68 | $0.67 | $0.65 - $0.68 | +1.49% | Beat | +3.0% | 5 | N/A | Aug 2, 2018 | $253.98M |
| Mar 31, 2018 | $0.62 | $0.61 | $0.60 - $0.62 | +1.64% | Beat | +14.8% | 5 | N/A | May 10, 2018 | $2.34B |
| Dec 31, 2017 | $0.70 | $0.70 | $0.68 - $0.72 | 0.00% | In line | +14.8% | 6 | N/A | Feb 1, 2018 | $270.62M |
| Sep 30, 2017 | $0.61 | $0.66 | $0.66 - $0.67 | -7.58% | Miss | -3.2% | 5 | N/A | Nov 2, 2017 | $258.03M |
| Jun 30, 2017 | $0.66 | $0.64 | $0.61 - $0.66 | +3.13% | Beat | +11.9% | 6 | N/A | Aug 3, 2017 | $256.57M |
| Mar 31, 2017 | $0.54 | $0.55 | N/A | -1.82% | Miss | +3.8% | N/A | N/A | May 11, 2017 | $240.67M |
| Dec 31, 2016 | $0.61 | $0.56 | N/A | +8.93% | Beat | +15.1% | N/A | N/A | Feb 2, 2017 | $216.76M |
Annual EPS
EPS for the fiscal year ended Mar 31, 2026 was $4.18, down 7.7% from the year before. It was $2.37 for the year ended Mar 31, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Mar 31, 2026 | $4.18 | -7.7% |
| Mar 31, 2025 | $4.53 | +7.6% |
| Mar 31, 2024 | $4.21 | N/A |
| Mar 31, 2023 | $4.22 | +3.9% |
| Mar 31, 2022 | $4.06 | +25.3% |
| Mar 31, 2021 | $3.24 | +9.5% |
| Mar 31, 2020 | $2.96 | +6.5% |
| Mar 31, 2019 | $2.78 | +7.3% |
| Mar 31, 2018 | $2.59 | +9.3% |
| Mar 31, 2017 | $2.37 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,400 words across 10 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 4,351 | 10 | |
| 2026Q2 | Jun 30, 2026 | 5,886 | 11 | |
| 2026Q1 | Mar 31, 2026 | 4,461 | 8 | |
| 2025Q4 | Dec 31, 2025 | 5,377 | 9 | |
| 2025Q3 | Sep 30, 2025 | 4,365 | 10 | |
| 2025Q2 | Jun 30, 2025 | 3,606 | 7 | |
| 2025Q1 | Mar 31, 2025 | 4,637 | 10 | |
| 2024Q4 | Dec 31, 2024 | 6,877 | 9 |
2026Q3 Earnings Call
Opening remarks
Philip Terpolilli Vice President, Investor Relations and Treasury Thanks, operator. And thank you to everyone who has joined today. On the call with me are Ron Lombardi, our Chairman, President, and CEO, and Christine Sacco, our CFO and COO. On today's call, we'll review our third quarter fiscal 2026 results, discuss our full-year outlook, and then take questions from analysts. The slide presentation accompanying today's call can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the investors link, and then on today's webcast and presentation. Remember, some of the information contained in the presentation today includes non-GAAP financial measures. Reconciliations to the nearest GAAP financial measures are included in our earnings release and slide presentation. On today's call, management will make forward-looking statements around risks and uncertainties, which are detailed in a complete safe harbor on page two of the slide presentation that accompanies the call. These are important to review and contemplate. Business environment uncertainty remains heightened due to supply chain constraints, high inflation, and geopolitical events, which have numerous potential impacts. This means results could change at any time, and the forecasted impact of risk considerations is the best estimate based on the information available as of today's date. Additional information concerning risk factors and cautionary statements are available in our most recent SEC filings and the most recent company 10-K. And I'll hand it over to our CEO, Ron Lombardi. Ron?
Ron Lombardi Chairman, President, and CEO Thanks, Phil. Let's begin on slide five. We delivered solid results for the third quarter, which reflected the benefits of our diverse business model and strong financial profile. We are pleased with these results, especially when navigating the challenging consumer backdrop we've seen year to date, which includes consumers changing where they shop in a fluid environment with tariff inflation, a government shutdown, public announcements related to acetaminophen, and more. All of this led to a dynamic environment in Q3 that we successfully managed through. Sales of $283 million were slightly better than forecast. Our diverse customer base allowed us to see solid order trends in our growing channels, which more than offset the impact of other channels that are more affected by the macro issues I just mentioned. Our broad distribution allows us to benefit from changes in consumer shopping habits no matter where they look to buy our trusted and leading brands. Another positive is that we continue to see sequential improvement in Clear Eyes supply for the second quarter in a row. We anticipate further improvements based on actions we've taken that I'll discuss shortly. Moving down the P&L, both gross margin of 55.5% and adjusted EPS of $1.14 were in line with our expectations provided on our second quarter call.
Frequently Asked Questions About PBH
When is Prestige Brand Holdings's next earnings date?
Prestige Brand Holdings's next earnings report is expected for Feb 3, 2027.
Did PBH beat earnings estimates last quarter?
Yes. Prestige Brand Holdings reported EPS of $1.13 for the quarter ended Sep 30, 2026, above the $1.06 estimate, a 6.60% surprise.
What EPS do analysts expect from PBH next quarter?
The consensus EPS estimate for Prestige Brand Holdings for the quarter ending Dec 31, 2026 is $1.05 from 6 analysts, with estimates from $1.05 to $1.06.
How often does PBH beat earnings estimates?
Prestige Brand Holdings beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -0.79%.
PBH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors